Based on the concerted actions of MAPK4-AKT and MAPK4-PDK1 signaling axis in driving MAPK4 tumor-promoting activities, we tested and confirmed that co-blockade of AKT and PDK1 effectively represses MAPK4-induced cancer cell growth (Fig 8). The gene discussed is PDK1; the disease is neoplasm.